Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment (Q46641346)
Jump to navigation
Jump to search
scientific article published in August 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment |
scientific article published in August 1998 |
Statements
1 reference
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment (English)
1 reference
M D Pegram
1 reference
A Lipton
1 reference
D F Hayes
1 reference
B L Weber
1 reference
J M Baselga
1 reference
D Tripathy
1 reference
D Baly
1 reference
S A Baughman
1 reference
T Twaddell
1 reference
J A Glaspy
1 reference
D J Slamon
1 reference
1 August 1998
1 reference
1 reference
16
1 reference
2659-2671
1 reference
8
1 reference
Identifiers
1 reference
1 reference